Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Dana-Farber Cancer Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Brigham and Women's Hospital
Massachusetts General Hospital
AstraZeneca
Information provided by:
Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00165308
First received: September 9, 2005
Last updated: October 30, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2010
  Primary Completion Date: May 2003 (Final data collection date for primary outcome measure)
No publications provided by Dana-Farber Cancer Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):